Which vaccine is used to protect against meningitis caused by Neisseria meningitidis?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Enhance your knowledge on healthy living with the HOSA Healthy Living Test. Dive into flashcards and multiple choice questions, each offering insights and expansions. Gear up for your upcoming test!

Multiple Choice

Which vaccine is used to protect against meningitis caused by Neisseria meningitidis?

Explanation:
The vaccine used to protect against meningitis caused by Neisseria meningitidis is MenAfriVac. This vaccine specifically targets the serogroup A strain of the bacteria, which is responsible for outbreaks of meningococcal disease, especially in sub-Saharan Africa. MenAfriVac has been instrumental in reducing the incidence of meningitis in regions where this strain is prevalent. On the other hand, the MMR vaccine protects against measles, mumps, and rubella, but it does not provide any protection against meningococcal infections. TDAP is designed to protect against tetanus, diphtheria, and pertussis (whooping cough) and is unrelated to meningitis caused by Neisseria meningitidis. The Hepatitis B vaccine targets the Hepatitis B virus and does not confer protection against meningococcal disease. Thus, MenAfriVac is the appropriate choice for preventing meningitis linked to this specific bacterium.

The vaccine used to protect against meningitis caused by Neisseria meningitidis is MenAfriVac. This vaccine specifically targets the serogroup A strain of the bacteria, which is responsible for outbreaks of meningococcal disease, especially in sub-Saharan Africa. MenAfriVac has been instrumental in reducing the incidence of meningitis in regions where this strain is prevalent.

On the other hand, the MMR vaccine protects against measles, mumps, and rubella, but it does not provide any protection against meningococcal infections. TDAP is designed to protect against tetanus, diphtheria, and pertussis (whooping cough) and is unrelated to meningitis caused by Neisseria meningitidis. The Hepatitis B vaccine targets the Hepatitis B virus and does not confer protection against meningococcal disease. Thus, MenAfriVac is the appropriate choice for preventing meningitis linked to this specific bacterium.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy